ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein

Li, Yan; Wan, Yuhua; Liu, Peipei; Zhao, Jincun; Lu, Guangwen; Qi, Jianxun; Wang, Qihui; Lu, Xuancheng; Wu, Ying; Liu, Wenjun; Zhang, Buchang; Yuen, Kwok-Yung; Perlman, Stanley; Gao, George F.; Yan, Jinghua*广州医学院; 四川大学; 1
Cell Research2015-11DOI: 10.1038/cr.2015.113
112被引5阅读
引用收藏
分享

摘要

The newly-emerging Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe and fatal acute respiratory disease in humans. Despite global efforts, the potential for an associated pandemic in the future cannot be excluded. The development of effective counter-measures is urgent. MERS-CoV-specific anti-viral drugs or vaccines are not yet available. Using the spike receptor-binding domain of MERS-CoV (MERS-RBD) to immunize mice, we identified two neutralizing monoclonal antibodies (mAbs) 4C2 and 2E6. Both mAbs potently bind to MERS-RBD and block virus entry in vitro with high efficacy. We further investigated their mechanisms of neutralization by crystallizing the complex between the Fab fragments and the RBD, and solved the structure of the 4C2 Fab/MERS-RBD complex. The structure showed that 4C2 recognizes an epitope that partially overlaps the receptor-binding footprint in MERS-RBD, thereby interfering with the virus/receptor interactions by both steric hindrance and interface-residue competition. 2E6 also blocks receptor binding, and competes with 4C2 for binding to MERS-RBD. Based on the structure, we further humanized 4C2 by preserving only the paratope residues and substituting the remaining amino acids with the counterparts from human immunoglobulins. The humanized 4C2 (4C2h) antibody sustained similar neutralizing activity and biochemical characteristics to the parental mouse antibody. Finally, we showed that 4C2h can significantly abate the virus titers in lungs of Ad5-hCD26-transduced mice infected with MERS-CoV, therefore representing a promising agent for prophylaxis and therapy in clinical settings.

学科与关键词

关键词
MERS-CoVneutralizing monoclonal antibodyhumanizationcrystal structure
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cell Research
发表日期
2015-11
卷期
第 25 卷, 第 11 期
页码
1237-1249
DOI
10.1038/cr.2015.113
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCIE
资助标注
National Basic Research Program of China (973 Program) [2015CB910503]; National Science and Technology Major Project of China [2013ZX10004608-002, 2014ZX10004001-006]; National Natural Science Foundation of China (NSFC) [31400154, 81461168030]; National Institutes of Health, USA [AI60699]; Hong Kong Research Grants Council [NHKU728/14]

作者

  • L

    Li, Yan (第一作者)

    chinese acad sci, inst microbiol

  • W

    Wan, Yuhua

    chinese acad sci, inst microbiol · anhui univ

查看全部 15 位作者收起作者
  • L

    Liu, Peipei

    chinese acad sci, inst microbiol

  • Z

    Zhao, Jincun

    1 · guangzhou med univ

  • L

    Lu, Guangwen

    sichuan univ

  • Q

    Qi, Jianxun

    chinese acad sci, inst microbiol

  • W

    Wang, Qihui

    chinese acad sci, inst microbiol

  • L

    Lu, Xuancheng

    chinese ctr dis control & prevent china cdc

  • W

    Wu, Ying

    chinese acad sci, inst microbiol

  • L

    Liu, Wenjun

    chinese acad sci, inst microbiol

  • Z

    Zhang, Buchang

    anhui univ

  • Y

    Yuen, Kwok-Yung

    univ hong kong

  • P

    Perlman, Stanley

  • G

    Gao, George F.

    chinese acad sci, inst microbiol · chinese ctr dis control & prevent china cdc

  • Y

    Yan, Jinghua (通讯)

    chinese acad sci, inst microbiol · anhui univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417